26446211|t|APOE Isoforms Control Pathogenic Subretinal Inflammation in Age-Related Macular Degeneration.
26446211|a|Contrary to Alzheimer's disease (AD), the APOE2 allele increases and the APOE4 allele reduces the risk to develop age-related macular degeneration (AMD) compared with the most common APOE3 allele. The underlying mechanism for this association with AMD and the reason for the puzzling difference with AD are unknown. We previously demonstrated that pathogenic subretinal mononuclear phagocytes (MPs) accumulate in Cx3cr1-deficient mice due to the overexpression of APOE, interleukin-6, and CC chemokine ligand 2 (CCL2). We here show using targeted replacement mice expressing the human APOE isoforms (TRE2, TRE3, and TRE4) that MPs of TRE2 mice express increased levels of APOE, interleukin-6, and CCL2 and develop subretinal MP accumulation, photoreceptor degeneration, and exaggerated choroidal neovascularization similar to AMD. Pharmacological inhibition of the cytokine induction inhibited the pathogenic subretinal inflammation. In the context of APOE-dependent subretinal inflammation in Cx3cr1(GFP/GFP) mice, the APOE4 allele led to diminished APOE and CCL2 levels and protected Cx3cr1(GFP/GFP) mice against harmful subretinal MP accumulation observed in Cx3cr1(GFP/GFP)TRE3 mice. Our study shows that pathogenic subretinal inflammation is APOE isoform-dependent and provides the rationale for the previously unexplained implication of the APOE2 isoform as a risk factor and the APOE4 isoform as a protective factor in AMD pathogenesis. SIGNIFICANCE STATEMENT: The understanding of how genetic predisposing factors, which play a major role in age-related macular degeneration (AMD), participate in its pathogenesis is an important clue to decipher the pathomechanism and develop efficient therapies. In this study, we used transgenic, targeted replacement mice that carry the three human APOE isoform-defining sequences at the mouse APOE chromosomal location and express the human APOE isoforms. Our study is the first to show how APOE2 provokes and APOE4 inhibits the cardinal AMD features, inflammation, degeneration, and exaggerated neovascularization. Our findings reflect the clinical association of the genetic predisposition that was recently confirmed in a major pooled analysis. They emphasize the role of APOE in inflammation and inflammation in AMD.
26446211	0	4	APOE	Gene	348
26446211	33	56	Subretinal Inflammation	Disease	MESH:D007249
26446211	60	92	Age-Related Macular Degeneration	Disease	MESH:D008268
26446211	106	125	Alzheimer's disease	Disease	MESH:D000544
26446211	127	129	AD	Disease	MESH:D000544
26446211	136	141	APOE2	Gene	348
26446211	167	172	APOE4	Gene	348
26446211	208	240	age-related macular degeneration	Disease	MESH:D008268
26446211	242	245	AMD	Disease	MESH:D008268
26446211	342	345	AMD	Disease	MESH:D008268
26446211	394	396	AD	Disease	MESH:D000544
26446211	507	513	Cx3cr1	Gene	13051
26446211	524	528	mice	Species	10090
26446211	558	562	APOE	Gene	348
26446211	564	577	interleukin-6	Gene	16193
26446211	583	604	CC chemokine ligand 2	Gene	20296
26446211	606	610	CCL2	Gene	20296
26446211	653	657	mice	Species	10090
26446211	673	678	human	Species	9606
26446211	679	683	APOE	Gene	348
26446211	733	737	mice	Species	10090
26446211	766	770	APOE	Gene	348
26446211	772	785	interleukin-6	Gene	16193
26446211	791	795	CCL2	Gene	20296
26446211	819	821	MP	Disease	
26446211	836	862	photoreceptor degeneration	Disease	MESH:D009410
26446211	880	908	choroidal neovascularization	Disease	MESH:D020256
26446211	920	923	AMD	Disease	MESH:D008268
26446211	1003	1026	subretinal inflammation	Disease	MESH:D007249
26446211	1046	1050	APOE	Gene	348
26446211	1061	1084	subretinal inflammation	Disease	MESH:D007249
26446211	1088	1094	Cx3cr1	Gene	13051
26446211	1104	1108	mice	Species	10090
26446211	1114	1119	APOE4	Gene	348
26446211	1145	1149	APOE	Gene	348
26446211	1154	1158	CCL2	Gene	20296
26446211	1180	1186	Cx3cr1	Gene	13051
26446211	1196	1200	mice	Species	10090
26446211	1228	1230	MP	Disease	
26446211	1256	1262	Cx3cr1	Gene	13051
26446211	1276	1280	mice	Species	10090
26446211	1314	1337	subretinal inflammation	Disease	MESH:D007249
26446211	1341	1345	APOE	Gene	348
26446211	1441	1446	APOE2	Gene	348
26446211	1480	1485	APOE4	Gene	348
26446211	1520	1523	AMD	Disease	MESH:D008268
26446211	1644	1676	age-related macular degeneration	Disease	MESH:D008268
26446211	1678	1681	AMD	Disease	MESH:D008268
26446211	1857	1861	mice	Species	10090
26446211	1883	1888	human	Species	9606
26446211	1889	1893	APOE	Gene	348
26446211	1928	1933	mouse	Species	10090
26446211	1934	1938	APOE	Gene	348
26446211	1976	1981	human	Species	9606
26446211	1982	1986	APOE	Gene	348
26446211	2032	2037	APOE2	Gene	348
26446211	2051	2056	APOE4	Gene	348
26446211	2079	2082	AMD	Disease	MESH:D008268
26446211	2093	2105	inflammation	Disease	MESH:D007249
26446211	2316	2320	APOE	Gene	348
26446211	2324	2336	inflammation	Disease	MESH:D007249
26446211	2341	2353	inflammation	Disease	MESH:D007249
26446211	2357	2360	AMD	Disease	MESH:D008268
26446211	Association	MESH:D007249	348
26446211	Association	13051	348
26446211	Negative_Correlation	16193	348
26446211	Negative_Correlation	20296	348
26446211	Association	MESH:D000544	348
26446211	Association	MESH:D008268	348

